Barriers to implementation of the new targeted BCG vaccination in France: a cross sectional study

L Rossignol1, J-P Guthmann, S Kernéis

  • 1Département de Médecine Générale, UPMC Univ Paris 06, 27 rue de Chaligny, 75571 Paris cedex 12, France. rossignol@u707.jussieu.fr

Vaccine
|May 26, 2011
PubMed

Insights

BCG vaccination rates declined after mandatory policies ended in France. Factors like child

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • France ended universal and mandatory Bacillus Calmette-Guérin (BCG) vaccination, necessitating an assessment of vaccination influences.
  • Tuberculosis (TB) risk remains a concern, particularly for specific pediatric populations.
  • Understanding factors affecting BCG uptake is crucial for maintaining public health.

Purpose of the Study:

  • To evaluate factors impacting BCG vaccination coverage among children at risk for tuberculosis in France.
  • To identify general practitioner (GP) knowledge and perceptions related to BCG vaccination guidelines.

Main Methods:

  • A 2009 cross-sectional study involving 358 general practitioners (GPs) from the French Sentinel Network.
  • Inclusion of 920 children, with analysis of vaccination status for 261 identified as high-risk for TB.
  • Statistical analysis using an alternating logistic model to identify associated variables.

Main Results:

  • Only 44% of at-risk children (113/261) received BCG vaccination.
  • Key factors increasing vaccination probability included: older age (>6 months), residence in Paris/suburbs, planned travel to endemic areas, unfavorable living conditions, GP knowledge of guidelines, and perception of TB as common.
  • GPs with infectious disease training showed lower adherence to vaccination guidelines (OR=0.14).

Conclusions:

  • BCG vaccination coverage among at-risk children in France is suboptimal.
  • Targeted interventions addressing identified factors can improve BCG immunization rates.
  • Further investigation into the reluctance of GPs with specialized training is warranted.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...